Clinical Trials In San Francisco

Discover hundreds of clinical trials in San Francisco.
Search clinical trials in San Francisco by condition or phase.

e.g. Respiratory Diseases

San Francisco•Healthy volunteers: No

Filter results

Results: 2,143

Longitudinal Study of the Porphyrias

Recruiting

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

San Francisco, Los Angeles, Birmingham, Miamishow 11 more

Code:

NCT01561157

Conditions

Acute Porphyrias

Cutaneous Porphyrias

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Recruiting

Phase 1

Sponsor:

Viking Therapeutics, Inc.

Location:

Palo Alto, Gainesville, Baltimore, Seattle

Code:

NCT04973657

Conditions

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VK0214

Placebo

Electrical Stimulation for the Treatment of Optic Neuropathies

Recruiting

Sponsor:

Stanford University

Location:

Palo Alto

Code:

NCT05626426

Conditions

Glaucoma

Glaucoma, Open-Angle

Optic Nerve Diseases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Repetitive, Transorbital Alternating Current Stimulation (rtACS)

Study to Evaluate the Effects of Oral NMRA 335140 Versus Placebo in Participants With Major Depressive Disorder

Recruiting

Phase 3

Sponsor:

Neumora Therapeutics, Inc.

Location:

Torrance, Temecula, Sherman Oaks, San Joseshow 55 more

Code:

NCT06029426

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA 335140

Placebo

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

Recruiting

Phase 3

Sponsor:

DBV Technologies

Location:

San Francisco, San Jose, San Diego, Mission Viejoshow 41 more

Code:

NCT05741476

Conditions

Allergy, Peanut

Eligibility Criteria

Sex: All

Age: 4 - 7

Healthy Volunteers: Not accepted

Interventions

DBV712

Placebo

e.g. Respiratory Diseases

San Francisco•Healthy volunteers: No

Filter results

Results: 2,143

Longitudinal Study of the Porphyrias

Recruiting

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

San Francisco, Los Angeles, Birmingham, Miamishow 11 more

Code:

NCT01561157

Conditions

Acute Porphyrias

Cutaneous Porphyrias

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Recruiting

Phase 1

Sponsor:

Viking Therapeutics, Inc.

Location:

Palo Alto, Gainesville, Baltimore, Seattle

Code:

NCT04973657

Conditions

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VK0214

Placebo

Electrical Stimulation for the Treatment of Optic Neuropathies

Recruiting

Sponsor:

Stanford University

Location:

Palo Alto

Code:

NCT05626426

Conditions

Glaucoma

Glaucoma, Open-Angle

Optic Nerve Diseases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Repetitive, Transorbital Alternating Current Stimulation (rtACS)

Study to Evaluate the Effects of Oral NMRA 335140 Versus Placebo in Participants With Major Depressive Disorder

Recruiting

Phase 3

Sponsor:

Neumora Therapeutics, Inc.

Location:

Torrance, Temecula, Sherman Oaks, San Joseshow 55 more

Code:

NCT06029426

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA 335140

Placebo

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

Recruiting

Phase 3

Sponsor:

DBV Technologies

Location:

San Francisco, San Jose, San Diego, Mission Viejoshow 41 more

Code:

NCT05741476

Conditions

Allergy, Peanut

Eligibility Criteria

Sex: All

Age: 4 - 7

Healthy Volunteers: Not accepted

Interventions

DBV712

Placebo